The University of Texas System's audit revealed the termination of a costly $62 million collaboration between MD Anderson Cancer Center and IBM's Watson, initiated to develop the Oncology Expert Advisor for enhancing cancer care. Despite significant investments, the project, begun in 2012, faced numerous delays and scope expansions, ultimately covering only a limited range of cancers and failing to integrate with MD Anderson's electronic medical records. This termination occurred amidst the center's financial struggles, leading to job cuts, and while IBM defended the project's potential, MD Anderson seeks new partners to possibly revive it.
